DK3265583T3 - Fremgangsmåde til påvisning af aviær nekrotisk enteritis - Google Patents
Fremgangsmåde til påvisning af aviær nekrotisk enteritis Download PDFInfo
- Publication number
- DK3265583T3 DK3265583T3 DK16709297.2T DK16709297T DK3265583T3 DK 3265583 T3 DK3265583 T3 DK 3265583T3 DK 16709297 T DK16709297 T DK 16709297T DK 3265583 T3 DK3265583 T3 DK 3265583T3
- Authority
- DK
- Denmark
- Prior art keywords
- necrotic enteritis
- detecting avian
- avian necrotic
- detecting
- enteritis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562129293P | 2015-03-06 | 2015-03-06 | |
| EP15174270.7A EP3112474A1 (en) | 2015-06-29 | 2015-06-29 | Method of detecting avian necrotic enteritis |
| PCT/EP2016/053502 WO2016142146A2 (en) | 2015-03-06 | 2016-02-19 | Method of detecting avian necrotic enteritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3265583T3 true DK3265583T3 (da) | 2021-03-29 |
Family
ID=53510675
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16709297.2T DK3265583T3 (da) | 2015-03-06 | 2016-02-19 | Fremgangsmåde til påvisning af aviær nekrotisk enteritis |
| DK18173960.8T DK3412779T3 (da) | 2015-03-06 | 2016-02-19 | Fremgangsmåde til påvisning af aviær nekrotisk enteritis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18173960.8T DK3412779T3 (da) | 2015-03-06 | 2016-02-19 | Fremgangsmåde til påvisning af aviær nekrotisk enteritis |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180312905A1 (da) |
| EP (3) | EP3112474A1 (da) |
| JP (1) | JP6878284B2 (da) |
| KR (1) | KR102518565B1 (da) |
| CN (1) | CN108026579A (da) |
| CA (1) | CA2971825A1 (da) |
| DK (2) | DK3265583T3 (da) |
| ES (1) | ES2856855T3 (da) |
| HU (2) | HUE053199T2 (da) |
| MX (1) | MX2017011191A (da) |
| PL (1) | PL3265583T3 (da) |
| RU (1) | RU2712505C2 (da) |
| WO (1) | WO2016142146A2 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3391899B1 (en) * | 2011-12-14 | 2020-07-15 | The Board of Trustees of the University of Arkansas | Delivery of therapeutic agents by a collagen binding protein |
| JP7397440B2 (ja) | 2017-02-10 | 2023-12-13 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー | コラーゲン結合薬剤組成物およびその使用方法 |
| PL3622082T3 (pl) * | 2017-05-12 | 2023-07-31 | Evonik Operations Gmbh | Sposób wykrywania chorób wywołanych przez C. perfringens w stadzie ptaków |
| WO2018206690A1 (en) | 2017-05-12 | 2018-11-15 | Evonik Degussa Gmbh | Method for detecting c. perfringens induced diseases in animals |
| EP3785033A1 (en) * | 2018-04-24 | 2021-03-03 | Universiteit Gent | Intestinal and fecal biomarkers for intestinal health of poultry |
| CN112166198A (zh) * | 2018-05-29 | 2021-01-01 | 赢创运营有限公司 | 监测动物种群中病原体负荷的体外方法 |
| PL3807421T3 (pl) * | 2018-06-15 | 2024-02-26 | Evonik Operations Gmbh | Sposób wczesnego wykrywania wybuchu zapalenia jelit w populacji ptaków |
| CA3122457A1 (en) * | 2018-12-14 | 2020-06-18 | Evonik Operations Gmbh | In vitro method for detecting avian intestinal dysbiosis |
| WO2021074332A2 (en) * | 2019-10-16 | 2021-04-22 | Dsm Ip Assets B.V. | Landless monogastric animal production system |
| CN113444785B (zh) * | 2021-06-28 | 2022-06-21 | 甘肃农业大学 | 一种与仔猪C型产气荚膜梭菌感染性腹泻相关的ssc-miR-122-5p及其应用 |
| GB202117593D0 (en) * | 2021-12-06 | 2022-01-19 | Royal Veterinary College | Methods |
| CN115896138B (zh) * | 2022-10-12 | 2023-08-08 | 吉林大学 | 一种厌氧硫酸酯酶成熟酶基因、厌氧硫酸酯酶成熟酶及其制备方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639606A (en) | 1993-04-06 | 1997-06-17 | The University Of Rochester | Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
| AU6263999A (en) * | 1998-09-28 | 2000-04-17 | Chiron Corporation | Human genes and gene expression products |
| FR2788780B1 (fr) | 1999-01-27 | 2001-03-30 | Ap Cells Inc | Procede de preparation de vesicules membranaires |
| GB9927320D0 (en) | 1999-11-18 | 2000-01-12 | Chiron Spa | Exosome separation |
| US6812023B1 (en) | 2000-04-27 | 2004-11-02 | Anosys, Inc. | Methods of producing membrane vesicles |
| ATE459707T1 (de) * | 2003-06-30 | 2010-03-15 | Dnavec Research Inc | Negativ-strang rna-virus-vektoren, welche ein gen mit veränderten hypermutierbaren regionen tragen |
| WO2005019258A2 (en) * | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| MY149604A (en) * | 2005-04-18 | 2013-09-13 | Schering Plough Ltd | C.perfringens alpha toxoid vaccine |
| US8058000B2 (en) * | 2005-06-02 | 2011-11-15 | The United States Of America As Represented By The U.S. Environmental Protection Agency | Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment |
| EP2164862B1 (en) * | 2007-06-08 | 2015-07-22 | Australian Poultry CRC Pty Ltd | Clostridial toxin netb |
| CN102301002A (zh) * | 2008-11-12 | 2011-12-28 | 卡里斯生命科学卢森堡控股有限责任公司 | 使用外来体来确定表现型的方法和*** |
| EP2495025A1 (en) | 2011-03-04 | 2012-09-05 | Fresenius Medical Care Deutschland GmbH | Filter for the removal of micro-vesicles from biological fluids, methods and devices using such a filter |
| CN102697812B (zh) * | 2012-05-28 | 2013-08-14 | 山东农业大学 | 鸡胆汁来源的胞外体提取方法及其在免疫学上的应用 |
| CA2879337C (en) * | 2012-07-19 | 2021-11-30 | Atlantic Cancer Research Institute | Method for the isolation of microvesicles |
| KR101922128B1 (ko) | 2012-12-04 | 2019-02-13 | 삼성전자주식회사 | 미세유동장치 및 이를 채용한 생물학적 시료 내의 표적 물질 농축방법 |
| EP2746406B1 (en) | 2012-12-18 | 2017-08-23 | Samsung Electronics Co., Ltd. | Composition and kit for diagnosing breast cancer including miRNAs within vesicle, and method of diagnosing breast cancer using the same |
| AU2014203987B2 (en) | 2013-01-03 | 2018-01-25 | Exosome Diagnostics, Inc. | Methods for isolating microvesicles |
| EP2959327A1 (en) | 2013-05-03 | 2015-12-30 | Halliburton Energy Services, Inc. | Non-contact fluid resistivity measurement |
-
2015
- 2015-06-29 EP EP15174270.7A patent/EP3112474A1/en not_active Withdrawn
-
2016
- 2016-02-19 DK DK16709297.2T patent/DK3265583T3/da active
- 2016-02-19 RU RU2017134856A patent/RU2712505C2/ru active
- 2016-02-19 MX MX2017011191A patent/MX2017011191A/es unknown
- 2016-02-19 US US15/555,531 patent/US20180312905A1/en active Pending
- 2016-02-19 JP JP2017541052A patent/JP6878284B2/ja active Active
- 2016-02-19 CA CA2971825A patent/CA2971825A1/en active Pending
- 2016-02-19 ES ES16709297T patent/ES2856855T3/es active Active
- 2016-02-19 WO PCT/EP2016/053502 patent/WO2016142146A2/en active Application Filing
- 2016-02-19 EP EP16709297.2A patent/EP3265583B1/en active Active
- 2016-02-19 PL PL16709297T patent/PL3265583T3/pl unknown
- 2016-02-19 DK DK18173960.8T patent/DK3412779T3/da active
- 2016-02-19 EP EP18173960.8A patent/EP3412779B1/en active Active
- 2016-02-19 KR KR1020177020797A patent/KR102518565B1/ko active IP Right Grant
- 2016-02-19 CN CN201680013933.1A patent/CN108026579A/zh active Pending
- 2016-02-19 HU HUE16709297A patent/HUE053199T2/hu unknown
- 2016-02-19 HU HUE18173960A patent/HUE055289T2/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE053199T2 (hu) | 2021-06-28 |
| KR102518565B1 (ko) | 2023-04-05 |
| BR112017018177A2 (pt) | 2018-04-10 |
| MX2017011191A (es) | 2018-01-23 |
| EP3412779A3 (en) | 2019-01-09 |
| RU2017134856A (ru) | 2019-04-08 |
| EP3412779A2 (en) | 2018-12-12 |
| KR20170120099A (ko) | 2017-10-30 |
| DK3412779T3 (da) | 2021-10-11 |
| WO2016142146A2 (en) | 2016-09-15 |
| PL3265583T3 (pl) | 2021-08-23 |
| RU2712505C2 (ru) | 2020-01-29 |
| WO2016142146A3 (en) | 2016-11-10 |
| EP3112474A1 (en) | 2017-01-04 |
| JP6878284B2 (ja) | 2021-05-26 |
| ES2856855T3 (es) | 2021-09-28 |
| HUE055289T2 (hu) | 2021-11-29 |
| US20180312905A1 (en) | 2018-11-01 |
| EP3265583B1 (en) | 2021-01-06 |
| RU2017134856A3 (da) | 2019-08-30 |
| EP3265583A2 (en) | 2018-01-10 |
| CN108026579A (zh) | 2018-05-11 |
| JP2018508204A (ja) | 2018-03-29 |
| EP3412779B1 (en) | 2021-07-14 |
| CA2971825A1 (en) | 2016-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3265583T3 (da) | Fremgangsmåde til påvisning af aviær nekrotisk enteritis | |
| DK3497207T3 (da) | Fremgangsmåder til påvisning af aav | |
| DK3419625T3 (da) | Fremgangsmåder til anvendelse af fxr-agonister | |
| DK3346961T3 (da) | Anordning til stomi | |
| DK3419624T3 (da) | Fremgangsmåder til anvendelse af fxr-agonister | |
| DK3072835T3 (da) | Fremgangsmåde til fremføring | |
| DK3286311T3 (da) | Fremgangsmåde til behandling af maligniteter | |
| DK3488485T3 (da) | Fremgangsmåde til tørring af elektrodeenheder | |
| DK3316703T3 (da) | Fremgangsmåde til forbedring af dyrs ydeevne | |
| DK3314010T3 (da) | Fremgangsmåde til detektering af kromosomaberrationer | |
| DK3365563T3 (da) | Forbindelseskomponent | |
| DK3359281T3 (da) | Fremgangsmåde til udtrækning af CO2 | |
| DK3317546T3 (da) | Fluidkomponent | |
| MA43367A (fr) | Inhibiteurs de métallo-bêta-lactamases | |
| DK3366832T3 (da) | Indretning til identifikation af stoftype | |
| DK3206586T3 (da) | Fremgangsmåde til detektion af dikrotisk hak | |
| DK3197506T3 (da) | Fremgangsmåde til tørring af et endoskops kanaler | |
| DK3373813T3 (da) | Indretning til ekstraktion af plasma | |
| DK3076224T3 (da) | Feltkartograf | |
| DK3256034T3 (da) | Vaskesystem til vaskeanordning | |
| DK3367910T3 (da) | Fremgangsmåde til anvendelse af en sondeafdækning | |
| DK3748358T3 (da) | Cellebaseret fremgangsmåde til bestemmelse af virkningsgraden af defibrotid | |
| DK3430072T3 (da) | Fremgangsmåde til oprensning af poloxamerer | |
| DK3265564T3 (da) | Fremgangsmåde til modulering af mecp2-ekspression | |
| DK3589742T3 (da) | Fremgangsmåde til detektering |